Covance appoints new head of expanded CV therapeutic area
This article was originally published in Scrip
Princeton, New Jersey-based Covance has named Dr Barry J Goldstein vice-president and global therapeutic area head of its expanded cardiovascular, metabolic, endocrine and renal unit. He will join Covance's medical and scientific affairs leadership team, based in Princeton. Dr Goldstein joins Covance from Merck where, since 2008, he served as vice-president in clinical research and therapeutic area head for diabetes and endocrinology.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.